Unity Biotechnology (UBX) 10-K 2023 FY Annual report

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1)

Registration Statements (Form S-3 Nos. 333-275924, 333-267886, 333-263574) of Unity Biotechnology, Inc.,

(2)

Registration Statement (Form S-8 No. 333-270567) pertaining to the 2018 Incentive Award Plan, 2018 Employee Stock Purchase Plan and 2020 Employment Inducement Incentive Award Plan, as amended of Unity Biotechnology, Inc.,

(3)

Registration Statements (Form S-8 Nos. 333-263576, 333-254619, 333-237088, 333-230086) pertaining to the 2018 Incentive Award Plan and 2018 Employee Stock Purchase Plan of Unity Biotechnology, Inc.,

(4)

Registration Statement (Form S-8 No. 333-250926) pertaining to the 2020 Employment Inducement Incentive Award Plan, as amended of Unity Biotechnology, Inc.,

(5)

Registration Statement (Form S-8 No. 333-237474) pertaining to the 2020 Employment Inducement Incentive Plan of Unity Biotechnology, Inc.,

(6)

Registration Statement (Form S-8 No. 333-224726) pertaining to the 2013 Equity Incentive Plan, 2018 Incentive Award Plan, and 2018 Employee Stock Purchase Plan of Unity Biotechnology, Inc.

of our report dated April 15, 2024, with respect to the financial statements of Unity Biotechnology, Inc. included in this Annual Report (Form 10-K) of Unity Biotechnology, Inc. for the year ended December 31, 2023.

/s/ Ernst & Young LLP

San Mateo, California

April 15, 2024